Your Healthcare Team

PHYSICIANS

All physicians at the Weill Cornell Breast Center are board-certified medical oncologists and members of the American Society of Clinical Oncology.

 

ANNE MOORE, MD
Medical Director, Weill Cornell Breast Center
Professor of Clinical Medicine, Weill Cornell Medicine
Attending Physician, NewYork-Presbyterian Hospital

Dr. Anne Moore is the Medical Director of the Weill Cornell Breast Center. She is Professor of Clinical Medicine at the Weill Cornell Medicine and Attending Physician at The NewYork-Presbyterian Hospital. Although her primary interest is patient care, she is involved in teaching and research both at the national and local level. Her laboratory research on platelets and endothelial cells was conducted at Weill Cornell Medical College with Dr.Ralph L Nachman. Her current clinical research involves breast cancer clinical trials and studies of side effects of medications commonly used in breast cancer.

She served as a Director of  the American Board of Internal Medicine and is an active member of the  American Society of Clinical Oncology where she is editor of the recent publication, ASCO-SEP II. In New York, she is a trustee of the New York Community Trust as well as a former trustee of The New York Academy of Medicine and past president of The New York Metropolitan Breast Cancer Group, Inc.  She is listed among “The Best Doctors” by American Health magazine and by New York magazine. She has been recognized by SHARE (Self-Help for Women with Breast Cancer), by JALBCA (Judges and Lawyers Breast Cancer Alliance), and by the Susan G. Komen Foundation for her work in breast cancer.

She was honored by The Artists for Breast Cancer Survival with a concert at Carnegie Hall. The Healthcare Chaplaincy recognized  her and her husband, Dr. Arnold L. Lisio with the Lifetime Achievment Award in 2007.  A graduate of Smith College and recipient of the alumna Gold Medal, she received her medical degree from Columbia College of Physicians and Surgeons and her post-graduate training at The New York Hospital.

LINDA VAHDAT, MD
Director, Breast Center Research Program
Chief of the Solid Tumor Service
Professor of Medicine, Weill Cornell Medicine

Attending Physician, NewYork-Presbyterian Hospital

Linda T. Vahdat, MD, MBA, is a Professor of Medicine at Weill Cornell Medicine as well as an Attending Physician at NewYork-Presbyterian Hospital in New York City. She is currently the Director of the Breast Cancer Research Program, at Weill Cornell Medicine and Co-Leader of the Breast Cancer Program within the Meyer Cancer Center. Until recently, she led the Solid Tumor Service at Weill Cornell, stepping down in 2015 to focus more on breast cancer-related activities.

Dr. Vahdat earned her undergraduate degree at Barnard College/Columbia University in New York City and completed her medical degree at Mount Sinai School of Medicine. She remained at Mount Sinai for her residency training in Internal Medicine and completed fellowship training in Medical Oncology and Hematology at the Memorial Sloan-Kettering Cancer Center (MSKCC). In 2014, Dr. Vahdat completed a master’s degree in business administration (MBA) at the Sloan School of Management at the Massachusetts Institute of Technology. She found it to be a perfect complement to her research activities since the program focused on management, operations, entrepreneurship and data analytics.

Although a translational breast cancer medical oncologist by training, Dr. Vahdat’s expertise is in drug development. She has been involved in the identification, conceptualization, design and execution of Phase 0 through III clinical trials of new therapies in high-risk adjuvant and metastatic breast cancer patients since 1994. She has led two separate drug development efforts that led to the FDA approval of two leading drugs to fight metastatic breast cancer, and her team has taken the lead for at least two other drugs that have a high probability of success, both in triple negative breast cancer. In 2014, she founded the Triple Negative Breast Cancer Clinic — one of only two dedicated clinics in the U.S. Dr. Vahdat’s other significant research interests include preventing breast cancer metastases and minimizing side effects of treatment, including chemotherapy-induced peripheral neuropathy. She is motivated to integrate new technology into translational medicine and has a number of collaborations both at Cornell Biogengineering and at MIT that she hopes will change how we view and treat cancer. She has also been actively involved and has held several leadership positions in the American Society of Clinical Oncology (ASCO), including Co-Chair of ASCO Breast Cancer Symposium. Dr. Vahdat also served on the Executive Board of Cancer Care from 2006 until 2012.

TESSA CIGLER, MD
Assistant Professor of Medicine, Weill Cornell Medicine
Assistant Attending Physician, NewYork-Presbyterian Hospital

Dr. Cigler is a medical oncologist whose work is dedicated to the treatment and prevention of breast cancer. She practices at the Weill Cornell Breast Center where comprehensive state-of-the-art care is provided in a personalized and warm environment. As a believer in the benefits of a multidisciplinary approach to breast cancer care, Dr. Cigler meets weekly with breast surgeons, radiation oncologists, pathologists, genetic counselors and other medical oncologists to ensure that her patients receive well-coordinated and optimal care.

Dr. Cigler pays careful attention to the short and long term effects of diagnosis and treatment on physical and emotional well being. She provides personalized and comprehensive care, addressing issues such as diet, exercise, fatigue, anxiety, bone health, and hormone mediated symptoms. For younger patients, options for fertility preservation are carefully considered as the treatment plan is formulated. Women are supported both during treatment and beyond, when attention shifts to issues of breast cancer survivorship. Dr. Cigler treats all stages of breast cancer and also counsels high risk women on options for breast cancer prevention.

Dr. Cigler is an active clinical investigator. As a member of the Weill Cornell Breast Center research team, she heads several clinical trials designed to provide her patients with access to the newest and most promising options for therapy. Her collaborative research focuses on ways to gain a better understanding of breast cancer pathogenesis and side effects of therapy, with the overall goal of improving breast cancer treatment and prevention.

Dr. Cigler teaches second year medical students at the Weill Cornell Medical College and mentors medical students and fellows on the wards. She is a member of the American Society of Clinical Oncology and the New York Metropolitan Breast Cancer Group. She is the author of several journal articles and book chapters.

ela9082ELENI ANDREOPOULOU, MD
Associate Professor of Clinical Medicine, Weill Cornell Medicine
Associate Attending Physician, NewYork-Presbyterian Hospital 

Dr. Andreopoulou joined Weill Cornell Medicine as an Associate Professor of Clinical Medicine specializing in the care and treatment of patients with breast cancer in January 2015. Prior to this appointment she held faculty positions at the Albert Einstein College of Medicine/ Montefiore Medical Center and the University of Texas M.D. Anderson Cancer Center.

Dr. Andreopoulou completed her training in major academic institutions in both Europe and the U.S. After she completed her residency in Internal Medicine at St Bartholomew`s Hospital in London she was awarded a European Society of Medical Oncology fellowship and trained in Medical Oncology at the Royal Marsden Hospital/Institute of Cancer Research in London, UK. She received laboratory training in the signal transduction and molecular pharmacology laboratory studying correlations between drug sensitivity and constitutive gene expression gaining a unique learning experience in a model hybrid clinical/laboratory facility. Subsequently, she completed her fellowship in Hematology and Medical Oncology at the New York University School of Medicine. In addition to intensive and comprehensive clinical training this experience was key to her understanding of the complexities in preclinical and clinical evaluation of anticancer drugs and established a strong foundation in her career. In addition to her active clinical practice her strength to the Weill Cornell Medical Center team is her demonstrated passion for biomarker-driven clinical trials, pharmacogenomic predictors of chemoresistance, chemosensitivity, and endocrine sensitivity for early and advanced stage breast cancer. Most importantly, she conceptualized and established a prospective bio-repository in breast cancer providing a crucial foundation for precision medicine research. She assembled this multidisciplinary team effort at Einstein/Montefiore and in collaboration with scientists used the bio specimens to probe one of the most perplexing challenges in modern clinical oncology – the issue of drug resistance and its relationship to chemotherapy-mediated dormancy.

At Weill Cornell Medicine, Dr. Andreopoulou continues to actively facilitate the interface between basic and applied research, and has a special interest in individualized patient treatment. Her main research interest is biomarker-based patient selection in early phase development to fast track drug development of biologics and targeted therapy to effectively treat breast cancer while sparing patients from unnecessary toxicity. Her focus is next generation -oncology trials and incorporating technology in drug development. Her goal, in collaboration with scientists, is to explore the relationship between cancer treatment, neoplastic cells and the immune system in order to improve understanding of the determinants of response to therapy. This has the potential to contribute critical information for future testing of combinations of immunotherapy and chemotherapy in breast cancer treatment.

She is an active investigator of several clinical trials of novel therapeutic approaches in advanced disease including her leadership role as a principal investigator in development of agents sponsored by the Cancer Therapy Evaluation Program at the National Cancer Institute.

Dr. Andreopoulou has published over 40 peer review articles, reviews, editorials and book chapters and has  been an invited speaker at international and national conferences.  She is a member of several scientific organizations including the American Society of Clinical Oncology, the American Association of Cancer Research and the Royal Society of Medicine. She has also been active with Breast Cancer awareness programs covering screening and prevention with a particular focus on underserved minorities.  She is also an active member of the American Women`s Medical Association.

NURSE PRACTITIONERS

SARAH SCHNEIDER, RN, ANP-BC

Ms. Schneider is a board-certified Adult Nurse Practitioner. She specializes in education and symptom management for breast cancer patients who undergo chemotherapy and hormonal therapy. She is also interested in breast cancer survivorship and feels that continued support of the patient beyond cancer treatment is crucial to long-term well-being. Ms. Schneider works with Weill Cornell Breast Center physicians to create follow-up care plans for patients and educational programs focusing on survivorship issues.

She graduated from the University of Michigan with a Bachelor of Arts in Psychology and received her Bachelor of Science in Nursing and a Master of Science in Nursing from Columbia University. Ms. Schneider completed an internship at the Breast Cancer Program of the Herbert Irving Comprehensive Cancer Center of Columbia University Medical Center. She joined the Weill Cornell Breast Center in 2009.